Simple and rapid detection of HLA-A*1:01 for prediction of carbamazepine-induced hypersensitivity using loop-mediated isothermal amplification method

Journal of Dermatological Science

Volumn 74, Issue 1, 2014, Pages 88-92

  Niihara, Hiroyuki ^a   Kohno, Kunie ^b   Taketani, Takeshi ^a   Kaneko, Sakae ^a   Ito, Takafumi ^a   Sugamori, Takashi ^a   Takahashi, Nobuyuki ^a   Miyaoka, Tuyoshi ^a   Okazaki, Shihoh ^a   Yasuda, Hideaki ^a   Furuya, Motohide ^a   Nagahama, Michiharu ^a   Morita, Eishin ^a  

^a SHIMANE UNIVERSITY HOSPITAL   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

Author keywords

31:01; Carbamazepine; Fatal severe cutaneous adverse reactions; Human leukocyte antigen A; Loop mediated isothermal amplification

Indexed keywords

CARBAMAZEPINE; GENOMIC DNA; HLA A ANTIGEN; ANTICONVULSIVE AGENT; HLA-A*31:01 ANTIGEN; PRIMER DNA;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DNA EXTRACTION; DRUG HYPERSENSITIVITY; EXON; GENE TARGETING; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; JAPANESE; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; RAPID TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SEVERE CUTANEOUS ADVERSE REACTIONS; SKIN ALLERGY; DNA SEQUENCE; DRUG EFFECTS; GENE FREQUENCY; GENETICS; JAPAN; MOLECULAR GENETICS; MORTALITY; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SKIN;

ALLELES; ANTICONVULSANTS; BASE SEQUENCE; CARBAMAZEPINE; DNA PRIMERS; DRUG HYPERSENSITIVITY; GENE FREQUENCY; GENOTYPE; HLA-A ANTIGENS; HUMANS; JAPAN; MOLECULAR SEQUENCE DATA; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SKIN;

EID: 84895928451     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.11.013     Document Type: Article

References (29)

1. Phillips E.J., Chung W.H., Mockenhaupt M., Roujeau J.C., Mallal S.A. Drug hypersensitivity: pharmacogenetics and clinical syndromes. J Allergy Clin Immunol 2011, 127:S60-S66.
2. Aihara M. Pharmacogenetics of cutaneous adverse drug reactions. J Dermatol 2011, 38:246-254.
3. Gerull R., Nelle M., Schaible T. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Crit Care Med 2011, 39:1521-1532.
4. Schneck J., Fagot J.P., Sekula P., Sassolas B., Roujeau J.C., Mockenhaupt M. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol 2008, 58:33-40.
5. Chung W.H., Hung S.I., Hong H.S., Hsih M.S., Yang L.C., Ho H.C., et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004, 428:486.
6. Man C.B., Kwan P., Baum L., Yu E., Lau K.M., Cheng A.S., et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 2007, 48:1015-1018.
7. Mehta T.Y., Prajapati L.M., Mittal B., Joshi C.G., Sheth J.J., Patel D.B., et al. Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol 2009, 75:579-582.
8. Tassaneeyakul W., Tiamkao S., Jantararoungtong T., Chen P., Lin S.Y., Chen W.H., et al. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia 2010, 51:926-930.
9. Chang C.C., Too C.L., Murad S., Hussein S.H. Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population. Int J Dermatol 2011, 50:221-224.
10. Chen P., Lin J.J., Lu C.S., Ong C.T., Hsieh P.F., Yang C.C., et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med 2011, 364:1126-1133.
11. Alfirevic A., Jorgensen A.L., Williamson P.R., Chadwick D.W., Park B.K., Pirmohamed M. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics 2006, 7:813-818.
12. Kashiwagi M., Aihara M., Takahashi Y., Yamazaki E., Yamane Y., Song Y., et al. Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients. J Dermatol 2008, 35:683-685.
13. Kaniwa N., Saito Y., Aihara M., Matsunaga K., Tohkin M., Kurose K., et al. HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilepsia 2010, 51:2461-2465.
14. Ozeki T., Mushiroda T., Yowang A., Takahashi A., Kubo M., Shirakata Y., et al. Genome-wide association study identifies HLA-A*101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet 2011, 20:1034-1041.
15. McCormack M., Alfirevic A., Bourgeois S., Farrell J.J., Kasperaviciute D., Carrington M., et al. HLA-A*101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 2011, 364:1134-1143.
16. Niihara H., Kakamu T., Fujita Y., Kaneko S., Morita E. HLA-A*1 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population. J Dermatol 2012, 39:594-610.
17. Aoki M., Hosono N., Takata S., Nakamura Y., Kamatani N., Kubo M. New pharmacogenetic test for detecting an HLA-A*1: 01 allele using the InvaderPlus assay. Pharmacogenet Genomics 2012, 22:441-446.
18. Notomi T., Okayama H., Masubuchi H., Yonekawa T., Watanabe K., Amino N.et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000, 28.
19. Iwasaki M., Yonekawa T., Otsuka K., Suzuki W., Nagamine K., Hase T., et al. Validation of the loop-mediated isothermal amplification method for single nucleotide polymorphism genotyping with whole blood. Genome Lett 2003, 2:119-126.
20. Nakamura N., Ito K., Takahashi M., Hashimoto K., Kawamoto M., Yamanaka M., et al. Detection of six single-nucleotide polymorphisms associated with rheumatoid arthritis by a loop-mediated isothermal amplification method and an electrochemical DNA chip. Anal Chem 2007, 79:9484-9493.
21. Nakamura N., Ito K., Takahashi M., Hongo S., Hashimoto K., Kawamoto M., et al. Clinical verification of a combination technology of a loop-mediated isothermal amplification method and an electrochemical DNA chip for personalized medicine. Clin Biochem 2009, 42(1158):1161.
22. Itoh Y., Mizuki N., Shimada T., Azuma F., Itakura M., Kashiwase K., et al. High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 2005, 57:717-729.
23. Sayer D., Whidborne R., Brestovac B., Trimboli F., Witt C., Christiansen F. HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors. Tissue Antigens 2001, 57:46-54.
24. Maekawa K., Nishikawa J., Kaniwa N., Sugiyama E., Koizumi T., Kurose K., et al. Development of a rapid and inexpensive assay for detecting a surrogate genetic polymorphism of HLA-B*58:01: a partially predictive but useful biomarker for allopurinol-related Stevens-Johnson syndrome/toxic epidermal necrolysis in Japanese. Drug Metab Pharmacokinet 2012, 27:447-450.
25. Kwok J., Kwong K.M. Detection of HLA-B*58:01, the susceptible allele for allopurinol induced hypersensitivity, by loop-mediated isothermal amplification. Br J Dermatol 2013, 168:526-532.
26. Kwok J., Kwong K.M. Loop-mediated isothermal amplification for detection of HLA-B*58:01 allele. Tissue Antigens 2013, 81:83-92.
27. Yip V.L., Marson A.G., Jorgensen A.L., Pirmohamed M., Alfirevic A. HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review. Clin Pharmacol Ther 2012, 92:757-765.
28. Furukawa H., Oka S., Shimada K., Tsuchiya R.A., Tohma S. HLA-A*1:01 and methotrexate-induced interstitial lung disease in Japanese rheumatoid arthritis patients: a multidrug hypersensitivity marker. Ann Rheum Dis 2013, 72:153-155.
29. Dong D., Sung C., Finkelstein E.A. Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore. Neurology 2012, 79:1259-1267.